See more : BRC Inc. (BRCC) Income Statement Analysis – Financial Results
Complete financial analysis of Sprint Bioscience AB (publ) (SPRINT.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sprint Bioscience AB (publ), a leading company in the Biotechnology industry within the Healthcare sector.
- Zhuzhou Hongda Electronics Corp.,Ltd. (300726.SZ) Income Statement Analysis – Financial Results
- Tribe Capital Growth Corp I (ATVCW) Income Statement Analysis – Financial Results
- Ecora Resources PLC (ECRAF) Income Statement Analysis – Financial Results
- Quizam Media Corporation (QQ.CN) Income Statement Analysis – Financial Results
- Kuang-Chi Technologies Co., Ltd. (002625.SZ) Income Statement Analysis – Financial Results
Sprint Bioscience AB (publ) (SPRINT.ST)
About Sprint Bioscience AB (publ)
Sprint Bioscience AB (publ) develops pharmaceutical products in the areas of cancer and metabolism in Sweden, Europe, the United States, and Asia. It engages in developing VPS34, a drug candidate for the treatment of various types of cancer; and PETRA01, a drug candidate for the treatment of cancer. The company also focuses on research of products for the treatment of tumor metabolism and type 2 diabetes. Sprint Bioscience AB (publ) was founded in 2009 and is based in Huddinge, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 50.49M | 83.00K | 35.11M | 16.89M | 33.54M | 17.94M | 23.97M | 34.99M | 7.73M | 4.61M | 2.37M | 1.59M | 2.37M |
| Cost of Revenue | 8.70M | 60.99M | 10.44M | 10.46M | 8.17M | 745.00K | 2.99M | 418.46K | -207.54K | -1.17M | -3.42M | -2.16M | 394.78K |
| Gross Profit | 41.79M | -60.91M | 24.68M | 6.43M | 25.37M | 17.19M | 20.98M | 34.57M | 7.93M | 5.78M | 5.79M | 3.75M | 1.97M |
| Gross Profit Ratio | 82.77% | -73,384.34% | 70.28% | 38.06% | 75.63% | 95.85% | 87.53% | 98.80% | 102.69% | 125.28% | 244.29% | 236.23% | 83.33% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.89M | 0.00 | 400.40K | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 22.18M | 21.11M | 18.29M | 17.22M | 13.19M | 11.06M | 9.33M | 3.77M | 3.33M | 2.62M | 829.64K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 42.63M | 47.44M | 22.18M | 21.11M | 18.29M | 17.22M | 13.19M | 11.06M | 9.33M | 3.77M | 3.33M | 2.62M | 829.64K |
| Other Expenses | 0.00 | 0.00 | 27.97M | 22.99M | 27.50M | 22.06M | 18.12M | 16.23M | 13.74M | 8.65M | 6.62M | 6.37M | 2.68M |
| Operating Expenses | 42.63M | 47.32M | 50.14M | 44.10M | 45.79M | 39.28M | 31.31M | 27.29M | 23.07M | 12.42M | 9.95M | 8.99M | 3.51M |
| Cost & Expenses | 51.33M | 60.99M | 60.58M | 54.56M | 53.96M | 40.02M | 34.30M | 27.70M | 22.86M | 11.26M | 6.53M | 6.82M | 3.91M |
| Interest Income | 794.00K | 1.00K | 269.00K | 3.44M | 1.21M | 0.00 | 0.00 | 167.00 | 1.28K | 4.40K | 1.00K | 2.03K | 5.56K |
| Interest Expense | 0.00 | 0.00 | 269.00K | 3.44M | 1.21M | 137.00K | 42.00K | 84.69K | 144.55K | 208.81K | 231.00K | 24.55K | 3.46K |
| Depreciation & Amortization | 447.00K | 618.00K | 590.00K | 697.00K | 742.00K | 693.00K | 564.00K | 451.23K | 208.04K | 386.47K | 309.00K | 68.55K | 5.00K |
| EBITDA | -2.08M | -60.00M | -24.49M | -38.05M | -19.59M | -31.06M | -10.06M | 5.08M | -15.15M | -10.87M | -3.85M | -5.17M | -1.53M |
| EBITDA Ratio | -4.12% | -72,639.76% | -68.99% | -228.93% | -58.43% | -119.17% | -41.96% | 30.99% | -196.04% | -235.76% | -162.25% | -325.23% | -64.65% |
| Operating Income | -845.00K | -60.91M | -25.47M | -37.68M | -20.42M | -22.06M | -10.67M | 4.57M | -15.36M | -11.26M | -4.16M | -5.24M | -1.54M |
| Operating Income Ratio | -1.67% | -73,384.34% | -72.52% | -223.13% | -60.88% | -122.99% | -44.51% | 13.05% | -198.75% | -244.24% | -175.28% | -329.68% | -65.10% |
| Total Other Income/Expenses | 407.00K | 739.00K | 383.00K | -4.94M | -1.30M | -156.00K | 5.00K | -25.00K | -143.10K | -204.41K | -230.31K | 1.69M | 28.54K |
| Income Before Tax | -438.00K | -60.17M | -25.08M | -42.79M | -21.54M | -22.22M | -10.66M | 4.54M | -15.50M | -11.46M | -4.39M | -3.55M | -1.51M |
| Income Before Tax Ratio | -0.87% | -72,493.98% | -71.43% | -253.43% | -64.21% | -123.86% | -44.49% | 12.98% | -200.61% | -248.67% | -185.03% | -223.21% | -63.89% |
| Income Tax Expense | 0.00 | 0.00 | 269.00K | 3.44M | 1.21M | 7.00K | -292.00K | 221.74K | -224.24K | 4.40K | 0.00 | 2.03K | -136.00K |
| Net Income | -438.00K | -60.17M | -25.35M | -46.23M | -22.74M | -22.22M | -10.66M | 4.54M | -15.50M | -11.46M | -4.39M | -3.55M | -1.38M |
| Net Income Ratio | -0.87% | -72,493.98% | -72.20% | -273.81% | -67.81% | -123.86% | -44.49% | 12.98% | -200.61% | -248.67% | -185.03% | -223.21% | -58.15% |
| EPS | -0.01 | -1.43 | -0.73 | -2.23 | -1.51 | -1.88 | -1.09 | 0.48 | -1.77 | -1.31 | -0.65 | -0.52 | -0.82 |
| EPS Diluted | -0.01 | -1.43 | -0.73 | -2.23 | -1.51 | -1.88 | -1.09 | 0.48 | -1.77 | -1.31 | -0.65 | -0.52 | -0.82 |
| Weighted Avg Shares Out | 69.81M | 42.06M | 34.65M | 20.70M | 15.04M | 11.85M | 9.81M | 9.12M | 8.77M | 8.77M | 6.76M | 6.76M | 1.67M |
| Weighted Avg Shares Out (Dil) | 69.81M | 42.06M | 34.65M | 20.70M | 15.04M | 11.85M | 9.81M | 9.12M | 8.77M | 8.77M | 6.76M | 6.76M | 1.67M |
Source: https://incomestatements.info
Category: Stock Reports